Lancet, 393(10184), 1937-1947. Elsevier Limited The Lancet, 393(10184), 1937-1947. Elsevier Lancet, Vol. 393, no. 10184, p. 1937-1947 (2019) LANCET, 393(10184), 1937-1947. ELSEVIER SCIENCE INC Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D E, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S W, Yi, T, Wigderson, M, de Zeeuw, D & Webb, D J 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184 . https://doi.org/10.1016/S0140-6736(19)30772-X Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S, Yi, T, Wigderson, M, de Zeeuw, D & SONAR Committees and Investigators 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) : a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184, pp. 1937-1947 . https://doi.org/10.1016/S0140-6736(19)30772-X
The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180